Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 56.12 USD 1.15% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Rhythm Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one RYTM stock under the Base Case scenario is 43.71 USD. Compared to the current market price of 56.12 USD, Rhythm Pharmaceuticals Inc is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RYTM Intrinsic Value
43.71 USD
Overvaluation 22%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Rhythm Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
RYTM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for RYTM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about RYTM?
Bearish
Neutral
Bullish

Fundamental Analysis

56.12 USD
+1.15%
+1.15%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Rhythm Pharmaceuticals Inc
US
Biotechnology
Market Cap
3.4B USD
IPO
Oct 5, 2017
Employees
140
United States of America
Market Cap
3.4B USD
Industry
Biotechnology
IPO
Oct 5, 2017
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Rhythm Pharmaceuticals Inc

Provide an overview of the primary business activities
of Rhythm Pharmaceuticals Inc.

What unique competitive advantages
does Rhythm Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Rhythm Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Rhythm Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Rhythm Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Rhythm Pharmaceuticals Inc.

Provide P/S
for Rhythm Pharmaceuticals Inc.

Provide P/E
for Rhythm Pharmaceuticals Inc.

Provide P/OCF
for Rhythm Pharmaceuticals Inc.

Provide P/FCFE
for Rhythm Pharmaceuticals Inc.

Provide P/B
for Rhythm Pharmaceuticals Inc.

Provide EV/S
for Rhythm Pharmaceuticals Inc.

Provide EV/GP
for Rhythm Pharmaceuticals Inc.

Provide EV/EBITDA
for Rhythm Pharmaceuticals Inc.

Provide EV/EBIT
for Rhythm Pharmaceuticals Inc.

Provide EV/OCF
for Rhythm Pharmaceuticals Inc.

Provide EV/FCFF
for Rhythm Pharmaceuticals Inc.

Provide EV/IC
for Rhythm Pharmaceuticals Inc.

Show me price targets
for Rhythm Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Rhythm Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Rhythm Pharmaceuticals Inc?

What are the Net Income projections
for Rhythm Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Rhythm Pharmaceuticals Inc?

What are the EPS projections
for Rhythm Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Rhythm Pharmaceuticals Inc?

What are the EBIT projections
for Rhythm Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Rhythm Pharmaceuticals Inc?

Compare the revenue forecasts
for Rhythm Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Rhythm Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Rhythm Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Rhythm Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Rhythm Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Rhythm Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Rhythm Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Rhythm Pharmaceuticals Inc.

Provide ROE
for Rhythm Pharmaceuticals Inc.

Provide ROA
for Rhythm Pharmaceuticals Inc.

Provide ROIC
for Rhythm Pharmaceuticals Inc.

Provide ROCE
for Rhythm Pharmaceuticals Inc.

Provide Gross Margin
for Rhythm Pharmaceuticals Inc.

Provide Operating Margin
for Rhythm Pharmaceuticals Inc.

Provide Net Margin
for Rhythm Pharmaceuticals Inc.

Provide FCF Margin
for Rhythm Pharmaceuticals Inc.

Show all solvency ratios
for Rhythm Pharmaceuticals Inc.

Provide D/E Ratio
for Rhythm Pharmaceuticals Inc.

Provide D/A Ratio
for Rhythm Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Rhythm Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Rhythm Pharmaceuticals Inc.

Provide Quick Ratio
for Rhythm Pharmaceuticals Inc.

Provide Current Ratio
for Rhythm Pharmaceuticals Inc.

Provide Cash Ratio
for Rhythm Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Rhythm Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Rhythm Pharmaceuticals Inc?

What is the current Free Cash Flow
of Rhythm Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Rhythm Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rhythm Pharmaceuticals Inc

Current Assets 340.3m
Cash & Short-Term Investments 298.4m
Receivables 19.3m
Other Current Assets 22.6m
Non-Current Assets 23.2m
PP&E 4.4m
Intangibles 6.4m
Other Non-Current Assets 12.5m
Current Liabilities 97.6m
Accounts Payable 4.9m
Accrued Liabilities 54.8m
Other Current Liabilities 37.9m
Non-Current Liabilities 113.3m
Long-Term Debt 109.2m
Other Non-Current Liabilities 4m
Efficiency

Earnings Waterfall
Rhythm Pharmaceuticals Inc

Revenue
112.5m USD
Cost of Revenue
-12.8m USD
Gross Profit
99.7m USD
Operating Expenses
-365.2m USD
Operating Income
-265.5m USD
Other Expenses
4m USD
Net Income
-261.5m USD

Free Cash Flow Analysis
Rhythm Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

RYTM Profitability Score
Profitability Due Diligence

Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

RYTM Solvency Score
Solvency Due Diligence

Rhythm Pharmaceuticals Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
64/100
Solvency
Score

Rhythm Pharmaceuticals Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 74.27 USD with a low forecast of 58.58 USD and a high forecast of 88.2 USD.

Lowest
Price Target
58.58 USD
4% Upside
Average
Price Target
74.27 USD
32% Upside
Highest
Price Target
88.2 USD
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for RYTM?

Click here to dive deeper.

Dividends

Rhythm Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RYTM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RYTM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

RYTM News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one RYTM stock?

The intrinsic value of one RYTM stock under the Base Case scenario is 43.71 USD.

Is RYTM stock undervalued or overvalued?

Compared to the current market price of 56.12 USD, Rhythm Pharmaceuticals Inc is Overvalued by 22%.

Back to Top